Blood Test Predicts Survival in Older Adults: New Research on piRNAs & Longevity
Blood Test Shows Promise in Predicting Short-Term Survival for Older Adults
DURHAM, N.C. — A new blood test analyzing small RNA molecules, known as piRNAs, can accurately predict whether adults aged 71 and older will survive at least two more years, according to a study led by Duke Health in collaboration with the University of Minnesota. The findings, published February 25 in Aging Cell, suggest a potential for earlier identification of survival risks and more targeted treatment strategies for promoting healthy aging.
Researchers discovered that lower levels of certain piRNAs were strongly correlated with longer survival. These molecules, previously known to regulate development, regeneration, and the immune system, emerged as a more powerful predictor of two-year survival than age, lifestyle habits, or other standard health measures, according to Virginia Byers Kraus, M.D., Ph.D., senior author of the study and professor in the departments of Medicine, Pathology and Orthopaedic Surgery at Duke University School of Medicine.
“What surprised us most was that this powerful signal came from a simple blood test,” Kraus said. The team analyzed 187 clinical factors and 828 different small RNAs in blood samples from over 1,200 participants, drawing from a long-running North Carolina health study established in the early 1990s. Survival outcomes were determined by linking participants to national mortality records.
Advanced statistical modeling revealed that a combination of just six piRNAs accurately predicted two-year survival in up to 86% of cases. The findings were validated in a separate group of older adults, bolstering the reliability of the model. Participants who lived longer consistently exhibited lower levels of these specific piRNAs, a pattern mirroring observations in simpler organisms where reducing piRNA levels can extend lifespan.
The study builds on previous research indicating a link between piRNAs and longevity. While piRNAs were traditionally believed to protect against DNA damage and instability, the Duke-led research suggests that higher levels of some of these molecules in the bloodstream may signal underlying health issues. “We know exceptionally little about piRNAs in the blood, but what we’re seeing is that lower levels of certain specific ones are better,” Kraus explained.
Researchers compared the predictive power of piRNA levels to more conventional health indicators. The blood test outperformed age, cholesterol levels, physical activity, and over 180 other clinical measures in predicting short-term survival. While lifestyle factors proved more influential in predicting longer-term survival, piRNAs continued to offer valuable insights into underlying biological processes.
The research team is now investigating whether interventions, lifestyle changes, or medications – including emerging therapies like GLP-1-based drugs – can alter piRNA levels. They likewise plan to compare piRNA levels in blood with those found within tissues to gain a deeper understanding of how these molecules function. Kraus described piRNAs as “like micromanagers in the body, helping control many processes that affect health and aging,” emphasizing that this research represents only a beginning in understanding their full potential.
Funding for the study was provided by the National Institutes of Health, including the National Institute on Aging, the National Center for Advancing Translational Sciences, and the National Heart, Lung, and Blood Institute.